The global Interventional Oncology Devices Markethas witnessed significant growth in recent years, driven by advancements in minimally invasive cancer treatments and the rising prevalence of cancer worldwide. According to recent market analysis, the market was valued at USD 3,970.77 million in 2024 and is projected to grow at a compound annual grow